Back to today’s briefing

Story perspectives

CVS Beats Q2 Forecast, Raises 2026 Guidance, Stock Drops 6%

8/6/2026

36 8 Full Breakdown

Summary

Story summary

CVS Health posted Q2 earnings of $2.58 per share versus $1.85 expected and revenue of $106.10 billion, beating the $100.11 billion forecast.
It raised 2026 profit guidance to $7.90-$8.10 per share and revenue outlook to at least $414 billion.
Shares fell 6% after the earnings call cited Caremark membership declines and a cautious stance on medical costs.
CVS teamed with Eli Lilly to provide Zepbound and Foundayo through its app by early Q4.

1 of 1

Story summary

CVS Health posted Q2 earnings of $2.58 per share versus $1.85 expected and revenue of $106.10 billion, beating the $100.11 billion forecast.
It raised 2026 profit guidance to $7.90-$8.10 per share and revenue outlook to at least $414 billion.
Shares fell 6% after the earnings call cited Caremark membership declines and a cautious stance on medical costs.
CVS teamed with Eli Lilly to provide Zepbound and Foundayo through its app by early Q4.